{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:07:01Z","timestamp":1792447621092,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.msard.2026.107093","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T16:23:17Z","timestamp":1771863797000},"page":"107093","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Chronic lesion expansion as an imaging biomarker in multiple sclerosis"],"prefix":"10.1016","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0614-1800","authenticated-orcid":false,"given":"Michael T G","family":"Hayes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi N","family":"Beadnall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Merlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mastura","family":"Monif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Klistorner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke","family":"van der Walt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Butzkueven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.msard.2026.107093_bib0001","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1172\/JCI86198","article-title":"Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions","volume":"126","author":"Absinta","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.msard.2026.107093_bib0002","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/jamaneurol.2019.2399","article-title":"Association of chronic active multiple sclerosis lesions with disability in vivo","volume":"76","author":"Absinta","year":"2019","journal-title":"JAMA Neurol."},{"issue":"7878","key":"10.1016\/j.msard.2026.107093_bib0003","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","article-title":"A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis","volume":"597","author":"Absinta","year":"2021","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.msard.2026.107093_bib0004","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000208058","article-title":"Effect of Evobrutinib on slowly expanding lesion volume in relapsing multiple sclerosis: a post hoc analysis of a phase 2 trial","volume":"102","author":"Arnold","year":"2024","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.msard.2026.107093_bib0005","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1093\/brain\/awae013","article-title":"Imaging chronic active lesions in multiple sclerosis: a consensus statement","volume":"147","author":"Bagnato","year":"2024","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.msard.2026.107093_bib0006","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2021-000240","article-title":"Chronic lesion activity and disability progression in secondary progressive multiple sclerosis","volume":"4","author":"Beynon","year":"2022","journal-title":"BMJ Neurol. Open"},{"issue":"17","key":"10.1016\/j.msard.2026.107093_bib0007","doi-asserted-by":"crossref","first-page":"e1783","DOI":"10.1212\/WNL.0000000000200144","article-title":"Association of slowly expanding lesions on MRI with disability in people with secondary progressive multiple sclerosis","volume":"98","author":"Calvi","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107093_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2022.103048","article-title":"Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosis","volume":"35","author":"Calvi","year":"2022","journal-title":"Neuroimage Clin."},{"issue":"3","key":"10.1016\/j.msard.2026.107093_bib0009","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1177\/13524585221141964","article-title":"Relationship between paramagnetic rim lesions and slowly expanding lesions in multiple sclerosis","volume":"29","author":"Calvi","year":"2023","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2026.107093_bib0010","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16092","article-title":"Treatment reduces the incidence of newly appearing multiple sclerosis lesions evolving into chronic active, slowly expanding lesions: a retrospective analysis","volume":"31","author":"Calvi","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2026.107093_bib0011","article-title":"Diffusivity anisotropy signature of the slowly expanding lesions predicts progression independent of relapse activity in multiple sclerosis","author":"Calvi","year":"2025","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.msard.2026.107093_bib0012","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/ana.25463","article-title":"Silent progression in disease activity\u2013free relapsing multiple sclerosis","volume":"85","author":"Cree","year":"2019","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2026.107093_bib0013","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00401-016-1636-z","article-title":"Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging","volume":"133","author":"Dal-Bianco","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.msard.2026.107093_bib0014","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/brain\/awaa436","article-title":"Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI","volume":"144","author":"Dal-Bianco","year":"2021","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.msard.2026.107093_bib0015","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/brain\/awz212","article-title":"Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis","volume":"142","author":"Elliott","year":"2019","journal-title":"Brain"},{"issue":"14","key":"10.1016\/j.msard.2026.107093_bib0016","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1177\/1352458518814117","article-title":"Slowly expanding\/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions","volume":"25","author":"Elliott","year":"2019","journal-title":"Mult. Scler."},{"issue":"9","key":"10.1016\/j.msard.2026.107093_bib0017","first-page":"1","article-title":"Patterning chronic active demyelination in slowly expanding\/evolving white matter MS lesions","volume":"41","author":"Elliott","year":"2020","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"6","key":"10.1016\/j.msard.2026.107093_bib0018","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1177\/13524585231162262","article-title":"Lesion-level correspondence and longitudinal properties of paramagnetic rim and slowly expanding lesions in multiple sclerosis","volume":"29","author":"Elliott","year":"2023","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.msard.2026.107093_bib0019","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ana.27066","article-title":"Slowly expanding lesions differentiate pediatric multiple sclerosis from myelin oligodendrocyte glycoprotein antibody disease","volume":"96","author":"Fadda","year":"2024","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2026.107093_bib0020","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3390\/ijms17040489","article-title":"Individual assessment of brain tissue changes in MS and the effect of focal lesions on short-term focal atrophy development in MS: a voxel-guided morphometry study","volume":"17","author":"Fox","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.msard.2026.107093_bib0021","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1055\/s-0028-1083689","article-title":"Picturing multiple sclerosis: conventional and diffusion tensor imaging","volume":"28","author":"Fox","year":"2008","journal-title":"Semin. Neurol."},{"issue":"19","key":"10.1016\/j.msard.2026.107093_bib0022","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa2415988","article-title":"Tolebrutinib in nonrelapsing secondary progressive multiple sclerosis","volume":"392","author":"Fox","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.msard.2026.107093_bib0023","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/brain\/awp070","article-title":"The relation between inflammation and neurodegeneration in multiple sclerosis brains","volume":"132","author":"Frischer","year":"2009","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.msard.2026.107093_bib0024","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ana.24497","article-title":"Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque","volume":"78","author":"Frischer","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2026.107093_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1290666","article-title":"Bioavailable central nervous system disease-modifying therapies for multiple sclerosis","volume":"14","author":"Hartung","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2026.107093_bib0026","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.3389\/fimmu.2017.01810","article-title":"Gene expression profiling of multiple sclerosis pathology identifies early patterns of demyelination surrounding chronic active lesions","volume":"8","author":"Hendrickx","year":"2017","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.msard.2026.107093_bib0027","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40263-015-0297-0","article-title":"The direct effects of Fingolimod in the Central nervous system: implications for relapsing multiple sclerosis","volume":"30","author":"Hunter","year":"2016","journal-title":"CNS Drugs"},{"issue":"7","key":"10.1016\/j.msard.2026.107093_bib0028","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1093\/brain\/awaa158","article-title":"Molecular signature of slowly expanding lesions in progressive multiple sclerosis","volume":"143","author":"J\u00e4ckle","year":"2020","journal-title":"Brain"},{"issue":"10422","key":"10.1016\/j.msard.2026.107093_bib0029","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(23)01473-3","article-title":"Multiple sclerosis","volume":"403","author":"Jakimovski","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.msard.2026.107093_bib0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/brain\/awy296","article-title":"Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions","volume":"142","author":"Kaunzner","year":"2019","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.msard.2026.107093_bib0031","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1177\/1352458520974357","article-title":"Expansion of chronic lesions is linked to disease progression in relapsing\u2013remitting multiple sclerosis patients","volume":"27","author":"Klistorner","year":"2021","journal-title":"Mult. Scler."},{"issue":"13","key":"10.1016\/j.msard.2026.107093_bib0032","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1177\/13524585221111684","article-title":"Mechanisms of central brain atrophy in multiple sclerosis","volume":"28","author":"Klistorner","year":"2022","journal-title":"Mult. Scler."},{"issue":"5","key":"10.1016\/j.msard.2026.107093_bib0033","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1177\/13524585211033464","article-title":"Expansion of chronic MS lesions is associated with an increase of radial diffusivity in periplaque white matter","volume":"28","author":"Klistorner","year":"2022","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107093_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105828","article-title":"Examining the relative contribution of slow-burning inflammation and chronic demyelination to axonal damage in chronic multiple sclerosis lesions","volume":"90","author":"Klistorner","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"3","key":"10.1016\/j.msard.2026.107093_bib0035","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200377","article-title":"Evolution of chronic lesion tissue in relapsing-remitting patients with multiple sclerosis: an association with disease progression","volume":"12","author":"Klistorner","year":"2025","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.msard.2026.107093_bib0036","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9440(10)64537-3","article-title":"Multiple sclerosis and chronic autoimmune encephalomyelitis : a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions","volume":"157","author":"Kornek","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.msard.2026.107093_bib0037","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41582-023-00800-7","article-title":"Bruton tyrosine kinase inhibitors for multiple sclerosis","volume":"19","author":"Kr\u00e4mer","year":"2023","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2026.107093_bib0038","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00401-016-1653-y","article-title":"An updated histological classification system for multiple sclerosis lesions","volume":"133","author":"Kuhlmann","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.msard.2026.107093_bib0039","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","article-title":"Multiple sclerosis progression: time for a new mechanism-driven framework","volume":"22","author":"Kuhlmann","year":"2023","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.msard.2026.107093_bib0040","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1111\/ene.15834","article-title":"Longitudinal stability of progression-related microglial activity during teriflunomide treatment in patients with multiple sclerosis","volume":"30","author":"Lehto","year":"2023","journal-title":"Eur. J. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2026.107093_bib0041","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/brain\/awac016","article-title":"How patients with multiple sclerosis acquire disability","volume":"145","author":"Lublin","year":"2022","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.msard.2026.107093_bib0042","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00401-018-1818-y","article-title":"Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis","volume":"135","author":"Luchetti","year":"2018","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.msard.2026.107093_bib0043","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJMoa020696","article-title":"A controlled trial of Natalizumab for relapsing multiple sclerosis","volume":"348","author":"Miller","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2026.107093_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(24)00328-4","article-title":"Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials","author":"Montalban","year":"2024","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.msard.2026.107093_bib0045","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1007\/s00415-022-11089-9","article-title":"Direction and magnitude of displacement differ between slowly expanding and non-expanding multiple sclerosis lesions as compared to small vessel disease","volume":"269","author":"Moog","year":"2022","journal-title":"J. Neurol."},{"issue":"11","key":"10.1016\/j.msard.2026.107093_bib0046","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1001\/jamaneurol.2023.3331","article-title":"Harmonizing definitions for progression independent of relapse activity in Multiple sclerosis: a systematic review","volume":"80","author":"M\u00fcller","year":"2023","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.msard.2026.107093_bib0047","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/13524585231224702","article-title":"Ibudilast reduces slowly enlarging lesions in progressive multiple sclerosis","volume":"30","author":"Nakamura","year":"2024","journal-title":"Mult. Scler."},{"issue":"11","key":"10.1016\/j.msard.2026.107093_bib0048","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1093\/brain\/awz287","article-title":"A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis","volume":"142","author":"Nutma","year":"2019","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.msard.2026.107093_bib0049","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/cts.13162","article-title":"Phase 1 clinical trial evaluating safety, exposure and pharmacodynamics of BTK inhibitor tolebrutinib (PRN2246, SAR442168)","volume":"15","author":"Owens","year":"2022","journal-title":"Clin. Transl. Sci."},{"issue":"10","key":"10.1016\/j.msard.2026.107093_bib0050","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1177\/1352458520969105","article-title":"Occurrence and microstructural features of slowly expanding lesions on fingolimod or natalizumab treatment in multiple sclerosis","volume":"27","author":"Preziosa","year":"2021","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.msard.2026.107093_bib0051","doi-asserted-by":"crossref","first-page":"e1139","DOI":"10.1212\/NXI.0000000000001139","article-title":"Slowly expanding lesions predict 9-year multiple sclerosis disease progression","volume":"9","author":"Preziosa","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"5","key":"10.1016\/j.msard.2026.107093_bib0052","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.1255","article-title":"Immunopathology of secondary-progressive multiple sclerosis","volume":"50","author":"Prineas","year":"2001","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2026.107093_bib0053","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.neuroimage.2006.12.010","article-title":"Diffusion tensor imaging of post mortem multiple sclerosis brain","volume":"35","author":"Schmierer","year":"2007","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.msard.2026.107093_bib0054","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/1352458516655403","article-title":"Slowly eroding lesions in multiple sclerosis","volume":"23","author":"Sethi","year":"2017","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2026.107093_bib0055","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neuroimage.2005.01.028","article-title":"Demyelination increases radial diffusivity in corpus callosum of mouse brain","volume":"26","author":"Song","year":"2005","journal-title":"Neuroimage"},{"issue":"9","key":"10.1016\/j.msard.2026.107093_bib0056","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1177\/1352458509106615","article-title":"Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief repeatable neuropsychological Battery and the Minimal Assessment of cognitive function in MS","volume":"15","author":"Strober","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107093_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104789","article-title":"Cross-talk between B cells, microglia and macrophages, and implications to central nervous system compartmentalized inflammation and progressive multiple sclerosis","volume":"96","author":"Touil","year":"2023","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.msard.2026.107093_bib0058","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40268-024-00468-4","article-title":"Comparative CNS pharmacology of the Bruton\u2019s tyrosine kinase (BTK) inhibitor Tolebrutinib versus other BTK inhibitor candidates for treating multiple sclerosis","volume":"24","author":"Turner","year":"2024","journal-title":"Drugs R. D."},{"issue":"4","key":"10.1016\/j.msard.2026.107093_bib0059","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1177\/13524585251316519","article-title":"Presence of slowly expanding lesions in multiple sclerosis predicts progressive demyelination within lesions and normal-appearing tissue over time","volume":"31","author":"Vavasour","year":"2025","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107093_bib0060","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fneur.2018.00092","article-title":"Understanding the physiopathology behind axial and radial diffusivity changes-what do we know?","volume":"9","author":"Winklewski","year":"2018","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2026.107093_bib0061","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/jon.13243","article-title":"Slowly expanding lesions are associated with disease activity and gray matter loss in relapse-onset multiple sclerosis","volume":"34","author":"Yokote","year":"2024","journal-title":"J. Neuroimaging"},{"issue":"6","key":"10.1016\/j.msard.2026.107093_bib0062","first-page":"987","article-title":"Quantitative susceptibility mapping of time-dependent susceptibility changes in multiple sclerosis lesions","volume":"40","author":"Zhang","year":"2019","journal-title":"AJNR Am. J. Neuroradiol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482600129X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482600129X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:22:30Z","timestamp":1781526150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103482600129X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":62,"alternative-id":["S221103482600129X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107093","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic lesion expansion as an imaging biomarker in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107093"}}